These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22336962)

  • 21. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
    Camacho NP; Carroll P; Raggio CL
    Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.
    Burr DB; Miller L; Grynpas M; Li J; Boyde A; Mashiba T; Hirano T; Johnston CC
    Bone; 2003 Dec; 33(6):960-9. PubMed ID: 14678856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.
    Geoffroy V; Paschalis EP; Libouban H; Blouin S; Ostertag A; Chappard D; Cros M; Phipps R; de Vernejoul MC
    Calcif Tissue Int; 2011 Jun; 88(6):464-75. PubMed ID: 21455736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass.
    Bonnick SL; Beck TJ; Cosman F; Hochberg MC; Wang H; de Papp AE
    Osteoporos Int; 2009 Jun; 20(6):911-21. PubMed ID: 18830555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
    Yano T; Yamada M; Inoue D
    Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
    Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
    J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.
    Fuchs RK; Phipps RJ; Burr DB
    J Bone Miner Res; 2008 Oct; 23(10):1689-97. PubMed ID: 18466070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates do not alter the rate of secondary mineralization.
    Fuchs RK; Faillace ME; Allen MR; Phipps RJ; Miller LM; Burr DB
    Bone; 2011 Oct; 49(4):701-5. PubMed ID: 21619951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.
    Zoehrer R; Roschger P; Paschalis EP; Hofstaetter JG; Durchschlag E; Fratzl P; Phipps R; Klaushofer K
    J Bone Miner Res; 2006 Jul; 21(7):1106-12. PubMed ID: 16813531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats.
    Yano T; Ito T; Kanehira Y; Yamada M; Kimura-Suda H; Wagatsuma H; Inoue D
    Bone Rep; 2021 Jun; 14():101061. PubMed ID: 33898659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.
    Mashiba T; Hirano T; Turner CH; Forwood MR; Johnston CC; Burr DB
    J Bone Miner Res; 2000 Apr; 15(4):613-20. PubMed ID: 10780852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats.
    Mosekilde L; Thomsen JS; Mackey MS; Phipps RJ
    Bone; 2000 Nov; 27(5):639-45. PubMed ID: 11062350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
    Borah B; Dufresne TE; Chmielewski PA; Johnson TD; Chines A; Manhart MD
    Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
    Saag K; Lindsay R; Kriegman A; Beamer E; Zhou W
    Bone; 2007 May; 40(5):1238-43. PubMed ID: 17347063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
    Ding M; Danielsen CC; Hvid I
    Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse.
    Yang Li C; Majeska RJ; Laudier DM; Mann R; Schaffler MB
    Bone; 2005 Sep; 37(3):287-95. PubMed ID: 16006205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.